Related Experiment Video
Updated: Jul 2, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
[Atheroembolic renal disease: a diagnostic challenge]
Francesco Scolari1, Silvia Turina, Chiara Venturelli
1Divisione di Nefrologia, Presidio di Montichiari dell'Azienda Ospedaliera Spedali Riuniti di Brescia, Montichiari. fscolar@tin.it
Atheroembolic renal disease, caused by cholesterol crystal emboli, leads to kidney failure. This multisystem condition, often linked to atherosclerosis, is frequently underdiagnosed.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Context:
- Atheroembolic renal disease (AERD) is a multisystem condition.
- It results from cholesterol crystal emboli obstructing renal arterioles and capillaries.
- The kidneys are commonly affected due to their proximity to the aorta and high blood flow.
Purpose:
- To define Atheroembolic renal disease.
- To highlight its association with atherosclerosis.
- To underscore its underdiagnosis and need for further research.
Summary:
- AERD involves renal failure from cholesterol crystal emboli originating from atheromatous plaques.
- Embolization can be spontaneous or triggered by procedures and anticoagulation.
- It affects other organs and extremities besides the kidneys.
Impact:
- AERD is an underdiagnosed contributor to kidney disease spectrum.
- Increased awareness can improve diagnosis and patient outcomes.
- Further nephrology research is crucial for understanding and managing AERD.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies